Back to Journals » OncoTargets and Therapy » Volume 10

Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib

Total article views   Abstract views HTML views PDF downloads Totals
10,399 Dovepress* 6,285 2,477+ 889 8,762
PubMed Central* 0 1,637 543 1,637
Totals 6,285 4,114 1,432 10,399
*Since 10 July 2017
+Since July 2016

View citations on PubMed Central and Google Scholar